Photo

Photo detail

David Van Meter

Stories this photo appears in:

Glaucoma Competitor Exit Gives Ivantis, Glaukos Boost

HEALTHCARE: FDA OK for Hydrus Microstent

Irvine-based Ivantis Inc., an 11-year-old ophthalmic device maker of eyelash-sized stents used to treat glaucoma, couldn’t pick a better time to bring its first product, Hydrus Microstent, to market in the U.S.

Tease photo